PMC:7243768 / 67614-67814
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T544 | 35-38 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T840 | 62-66 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 3, 5 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T93 | 123-127 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T500 | 0-200 | Sentence | denotes | The presence and quantification of RNA were carried out on 1, 3, 5, 7, 10, 14, 21, and 28 days after administration of the drug, and the samples were collected as nasopharyngeal, fecal and anal swabs. |